CANCER-LINKED GENE AS TARGET FOR CHEMOTHERAPY

Details for Australian Patent Application No. 2003213672 (hide)

Owner AVALON PHARMACEUTICALS

Inventors YOUNG, Paul, E.; EBNER, Reinhard; WEAVER, Zoe

Pub. Number AU-A-2003213672

PCT Number PCT/US03/06391

PCT Pub. Number WO2003/076571

Priority 60/361,461 04.03.02 US

Filing date 4 March 2003

Wipo publication date 22 September 2003

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/361,461 04.03.02 US

30 October 2003 Application Open to Public Inspection

  Published as AU-A-2003213672

18 November 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003213673-PIN1-MODULATING COMPOUNDS AND METHODS OF USE THEREOF

2003213671-PROCESSED CHEESE WITH IMPROVED FIRMNESS USING CROSSLINKING ENZYMES